The effects of high-dose calcitriol and individualized exercise on bone metabolism in breast cancer survivors on hormonal therapy: a phase II feasibility trial

Authors:

Abstract
Cancer treatment-induced bone loss (CTIBL) is a long-term side effect of breast cancer therapy. Both calcitriol and weight-bearing exercise improve bone metabolism for osteoporotic patients, but are unproven in a breast cancer population. We used a novel high-dose calcitriol regimen with an individualized exercise intervention to improve bone metabolism in breast cancer survivors.
Funding Information
  • National Cancer Institute (R25-CA102618, UG1-CA189961, K07-CA168886, K07-CA190529)
  • Division of Cancer Prevention, National Cancer Institute (K07-CA168911)
  • National Institutes of Health (DP2-CA195765)

This publication has 45 references indexed in Scilit: